GlassScriptPrepare for your visit
Christopher B Benton
Hematology & Oncology · Englewood, CO · NPI 1255667655
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$248,920.11
in general payments reported to CMS, 2019-2025 · $118K in 2025
The $118K reported for 2025 was more than what 99% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Who reported paying
General payments only, top 6 by amount.
- E.R. Squibb & Sons, L.L.C. $54,618.45
- Glaxosmithkline, LLC. $35,767.52
- Novartis Pharmaceuticals Corporation $32,053.35
- Alexion Pharmaceuticals, INC. $31,866.76
- Amgen INC. $15,117.06
- Abbvie INC. $14,336.55
Drugs and devices associated with these payments
Reblozyl Ojjaara Blincyto Venclexta Rytelo Scemblix Jakafi Vonjo Ultomiris Inqovi Revuforj Fabhalta
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Christopher Benton listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/541703/christopher-b-benton